YU227181A - Process for obtaining 3-aryl-5-isothiazole derivatives - Google Patents

Process for obtaining 3-aryl-5-isothiazole derivatives

Info

Publication number
YU227181A
YU227181A YU02271/81A YU227181A YU227181A YU 227181 A YU227181 A YU 227181A YU 02271/81 A YU02271/81 A YU 02271/81A YU 227181 A YU227181 A YU 227181A YU 227181 A YU227181 A YU 227181A
Authority
YU
Yugoslavia
Prior art keywords
aryl
obtaining
isothiazole derivatives
isothiazole
derivatives
Prior art date
Application number
YU02271/81A
Other languages
English (en)
Inventor
J R Beck
R P Gajewski
R E Hackler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU227181A publication Critical patent/YU227181A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU02271/81A 1980-09-22 1981-09-21 Process for obtaining 3-aryl-5-isothiazole derivatives YU227181A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,435 US4346094A (en) 1980-09-22 1980-09-22 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

Publications (1)

Publication Number Publication Date
YU227181A true YU227181A (en) 1983-10-31

Family

ID=22697314

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02271/81A YU227181A (en) 1980-09-22 1981-09-21 Process for obtaining 3-aryl-5-isothiazole derivatives

Country Status (22)

Country Link
US (1) US4346094A (pt)
EP (1) EP0048615B1 (pt)
JP (1) JPS5785379A (pt)
KR (1) KR830007597A (pt)
AR (1) AR229103A1 (pt)
AT (1) ATE7657T1 (pt)
AU (1) AU7551681A (pt)
CS (1) CS228536B2 (pt)
DD (1) DD201790A5 (pt)
DE (1) DE3163900D1 (pt)
DK (1) DK417981A (pt)
ES (1) ES8301225A1 (pt)
FI (1) FI812940L (pt)
GB (1) GB2084573B (pt)
GR (1) GR75046B (pt)
IL (1) IL63890A0 (pt)
NO (1) NO813208L (pt)
PL (1) PL130497B1 (pt)
PT (1) PT73711B (pt)
RO (1) RO82216A (pt)
YU (1) YU227181A (pt)
ZA (1) ZA816549B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428956A (en) 1980-12-29 1984-01-31 Merck & Co., Inc. 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4431652A (en) * 1980-12-29 1984-02-14 Merck & Co., Inc. 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4539328A (en) * 1983-03-25 1985-09-03 Fmc Corporation Nematicidal isothiazole derivatives
US4620865A (en) * 1983-11-07 1986-11-04 Eli Lilly And Company Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
ATE142494T1 (de) * 1990-11-30 1996-09-15 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
MY117352A (en) * 1995-10-31 2004-06-30 Ciba Sc Holding Ag Oximesulfonic acid esters and the use thereof as latent sulfonic acids.
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
TW575792B (en) * 1998-08-19 2004-02-11 Ciba Sc Holding Ag New unsaturated oxime derivatives and the use thereof as latent acids
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
CN100475798C (zh) 2002-02-06 2009-04-08 西巴特殊化学品控股有限公司 磺酸衍生物及其作为潜酸的用途
WO2006022374A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルピリジン誘導体
WO2006022375A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルチオフェン誘導体
DE602006018635D1 (de) 2005-10-07 2011-01-13 Astellas Pharma Inc Triarylcarbonsäurederivat
EP1992361B1 (en) 2006-02-24 2012-05-02 Astellas Pharma Inc. Remedy or preventive for digestive ulcer
GB2450975B (en) 2007-07-12 2010-02-24 Ciba Holding Inc Yellow radiation curing inks
CN102333765B (zh) 2009-02-27 2015-01-14 帝人制药株式会社 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法
WO2010112408A1 (en) 2009-03-30 2010-10-07 Basf Se Uv-dose indicator films
SG187843A1 (en) 2010-08-27 2013-03-28 Teijin Pharma Ltd Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
KR101897842B1 (ko) 2011-01-28 2018-09-12 바스프 에스이 열 경화제로서 옥심 술포네이트를 포함하는 중합성 조성물
EP2980085B1 (en) 2013-03-29 2018-03-14 Teijin Pharma Limited Pyrazole derivative
CN106604912A (zh) 2014-08-29 2017-04-26 巴斯夫欧洲公司 肟磺酸酯衍生物
WO2016174043A1 (de) 2015-04-29 2016-11-03 Bsn Medical Gmbh Mehrstufiges verfahren zur no-herstellung
BR112017023170B1 (pt) 2015-04-29 2022-08-16 Bsn Medical Gmbh Dispositivo de banho medicinal e seu uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178604A (en) * 1966-03-21 1970-01-21 American Cyanamid Co Novel Pyridinium Salts and Methods for Preparing Same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
GB1192701A (en) * 1968-03-22 1970-05-20 Ici Ltd Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same
US3681498A (en) * 1970-10-19 1972-08-01 American Cyanamid Co Isothiazolyl pyridinium salts as hypoglycemic agents

Also Published As

Publication number Publication date
US4346094A (en) 1982-08-24
ZA816549B (en) 1983-04-27
EP0048615B1 (en) 1984-05-30
IL63890A0 (en) 1981-12-31
AR229103A1 (es) 1983-06-15
RO82216A (ro) 1983-07-07
PT73711B (en) 1982-12-20
PT73711A (en) 1981-10-01
ATE7657T1 (de) 1984-06-15
EP0048615A1 (en) 1982-03-31
GB2084573B (en) 1984-09-12
CS228536B2 (en) 1984-05-14
ES505678A0 (es) 1982-12-01
DE3163900D1 (en) 1984-07-05
ES8301225A1 (es) 1982-12-01
KR830007597A (ko) 1983-11-04
PL130497B1 (en) 1984-08-31
GB2084573A (en) 1982-04-15
GR75046B (pt) 1984-07-12
RO82216B (ro) 1983-06-30
JPS5785379A (en) 1982-05-28
DK417981A (da) 1982-03-23
NO813208L (no) 1982-03-23
FI812940L (fi) 1982-03-23
PL233103A1 (pt) 1982-12-20
AU7551681A (en) 1982-04-01
DD201790A5 (de) 1983-08-10

Similar Documents

Publication Publication Date Title
YU221681A (en) Process for obtaining n-arylbenzamide derivatives
YU43051B (en) Process for preparing 1-sulfo-2-oxo-azetidine derivatives
YU227181A (en) Process for obtaining 3-aryl-5-isothiazole derivatives
PT73186A (en) Process for preparing pyrazolopyrydazine derivatives
YU98081A (en) Process for obtaining imidosulfamide derivatives
DE3160156D1 (en) Process for preparing vinylphosphonic-acid derivatives
YU42076B (en) Process for obtaining 2-guanidino-4-heteroarythiazoles
YU221581A (en) Process for obtaining isoxazolyl-benzamides
YU164481A (en) Process for obtaining isoxazolyl-imidazolidinone
YU42592B (en) Process for preparing 3-amino-propoxyphenyl derivatives
YU81181A (en) Process for obtaining substituted derivatives
PT73113A (en) Process for preparing substituted phenoxy-aminopropanol derivatives
YU217582A (en) Process for obtaining azolyl-pentene derivatives
YU252981A (en) Process for obtaining 11-dodecene-1-yl derivatives
PT74153A (en) Process for preparing oxadiazolopyrimidine derivatives
YU159481A (en) Process for preparing dibenzindole derivatives
YU243681A (en) Process for obtaining buspyrone
PT73457A (en) Process for preparing heteroprostaglandin derivatives
YU42413B (en) Process for obtaining dephenylether derivatives
HK91086A (en) Process for preparing 16alpha-hydroxy-17alpha-aminopregnane derivatives
YU217981A (en) Process for obtaining 4-carbamoyloxy-oxaphosphorine
YU246381A (en) Process for obtaining cephalexine derivatives
YU71081A (en) Process for obtaining 2-haloacetamides
YU184881A (en) Process for obtaining 4-amino-12-dihydrocarbyl-pyrazolidine
YU13881A (en) Process for obtaining l-asparagyl-d-amino-acid derivatives